Pharma & Biotech

The inclusion of Compass Therapeutics in the S&P Biotechnology Select Industry Index represents a significant validation for the clinical-stage biotech...

A previously under-the-radar biotechnology firm, Astria Therapeutics, is now commanding significant market attention following the release of encouraging early-stage clinical...

Iovance Biotherapeutics has made a significant corporate announcement, detailing the issuance of new stock options. This move directly impacts the...

Tandem Diabetes Care finds itself at a critical juncture, pulled in opposite directions by promising clinical developments and a serious...

After an extended period of decline, BioNTech stock is showing signs of a potential recovery. Investor sentiment received a dual...

After a period of significant volatility, shares of Coherus BioSciences are demonstrating renewed momentum. The biotech firm's dramatic strategic shift...

Pacific Biosciences is mounting a strategic product offensive in an attempt to reverse its persistent downward trend. The genomics company,...

A high-stakes patent dispute with pharmaceutical titan Merck has emerged as the dominant factor influencing Halozyme Therapeutics' stock trajectory. While...

Laboratory of America Holdings (Labcorp) finds itself at the center of a tug-of-war between bullish and bearish analysts this week....

The shares of biopharmaceutical firm Akebia Therapeutics are navigating a period of significant volatility. While a minor stabilization has emerged...